ALB and lymphoma: Pre-treatment serum albumin concentration has been used as a prognostic indicator for various neoplastic diseases such as non-small cell lung cancer [19], colorectal carcinoma [20], acute amyloid leukemia [21], and lymphoma [22–24] in humans.